[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367590-105":59,"doc-detail-367590-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","hsd3b1-c1100c-genotype-is-associated-with-distinct-tumoral-and-clinical-outcomes-in-breast-and-endometrial-cancers","HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers","","HSD3B1 encodes an enzyme converting adrenal precursors into potent sex steroids, and the germline variant c.1100C is linked to breast cancer progression. The study addresses whether HSD3B1 genotypes shape transcriptional and phenotypic tumor effects, influenced by hormonal signaling, including context around menopausal status. Using diagnostic-clinic BC and EC cohorts with germline HSD3B1 AA/AC/CC inferred from tumor sequencing, transcriptomics and gene set enrichment reveal genotype- and menopause-dependent pathway differences, immune and hormone signaling enrichment, and altered marker positivity and copy-number gains.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hsd3b1-c1100c-genotype-is-associated-with-distinct-tumoral-and-clinical-outcomes-in-breast-and-endometrial-cancers/367590/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hsd3b1-c1100c-genotype-is-associated-with-distinct-tumoral-and-clinical-outcomes-in-breast-and-endometrial-cancers/367590.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the HSD3B1 c.1100C germline variant affect in this study?","Question",{"text":113,"@type":114},"It evaluates how the HSD3B1 c.1100 genotype (AA, AC, CC) is associated with differences in tumor biology and clinical-related outcomes in breast and endometrial cancers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were HSD3B1 genotypes determined and how was menopausal status inferred?",{"text":118,"@type":114},"Genotypes were inferred from tumor DNA sequencing using variant allele frequency, and menopausal status was assumed using age at molecular profiling.",{"name":120,"@type":111,"acceptedAnswer":121},"What main differences were observed between genotypes in breast and endometrial cancers?",{"text":122,"@type":114},"In ER+ premenopausal breast cancer, CC tumors showed enrichment of hormone-related pathways; in premenopausal triple-negative breast cancer, AA tumors showed elevated immune/epithelial gene expression and higher MED12 alterations, while in endometrioid endometrial cancer CC tumors suppressed immune and proliferative pathways.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},367590,1790210704,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nHSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoraland Clinical Outcomes in Breast and Endometrial Cancers  \nNikitha Vobugari 1,2,†, Allison Makovec 1,2,†, Samuel Kellen 1,2, Shayan S. Nazari 3, Andrew Elliott 3, Devin Schmeck 1,2, Aiden Deacon 1,2, Gabriella von Dohlen 1,2, Emily John 1,2, Pedro C. Barata 4,  \nNeeraj Agarwal 5, Melissa A. Geller 2,6, Britt K. Erickson 2,6, George Sledge 3, Julie H. Ostrander 1,2, Rana R. McKay 7, Charles J. Ryan 8, Nima Sharifi 9, Emmanuel S. Antonarakis 1,2,* and Justin Hwang 1,2, *  \nAcademic Editor: Apostolos Zaravinos  \nReceived: 15 May 2025  \nRevised: 10 June 2025  \nAccepted: 12 June 2025  \nPublished: 14 June 2025  \nCitation: Vobugari, N.; Makovec, A.; Kellen, S.; Nazari, S.S.; Elliott, A.; Schmeck, D.; Deacon, A.; von Dohlen, G.; John, E.; Barata, P.C.; et al. HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomesin Breast and Endometrial Cancers. Int. J. Mol. Sci. 2025, 26, 5720 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26125720  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA;  \n[vobug002@umn.edu](vobug002@umn.edu) (N.V.); [makov016@umn.edu](makov016@umn.edu) (A.M.); [kell2658@umn.edu](kell2658@umn.edu) (S.K.);  \n[schme154@umn.edu](schme154@umn.edu) (D.S.); [adeacon@umn.edu](adeacon@umn.edu) (A.D.); [vondo025@umn.edu](vondo025@umn.edu) (G.v.D.); [joh21009@umn.edu](joh21009@umn.edu) (E.J.);  \n[hans1354@umn.edu](hans1354@umn.edu) (J.H.O.)  \n2 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; [gelle005@umn.edu](gelle005@umn.edu) (M.A.G.); [bkeric@umn.edu](bkeric@umn.edu) (B.K.E.)  \n3 Caris Life Sciences, Phoenix, AZ 85040, USA; [snazari@carisls.com](snazari@carisls.com) (S.S.N.); [aelliott@carisls.com](aelliott@carisls.com) (A.E.); [gsledge@carisls.com](gsledge@carisls.com) (G.S.)  \n4 Department of Internal Medicine, University Hospitals Seidman Cancer Center Case Western Reserve University, Cleveland, OH 44106, USA; [pedro.barata@uhhospitals.org](pedro.barata@uhhospitals.org)  \n5 Division of Medical Oncology, Huntsman Cancer Institute (NCI-CCC), University of Utah, Salt Lake City, UT 84112, USA; [neeraj.agarwal@hci.utah.edu](neeraj.agarwal@hci.utah.edu)  \n6 Department of Obstetrics and Gynecology, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA  \n7 Department of Medicine and Urology, UC San Diego School of Medicine, La Jolla, CA 92093, USA; [rmckay@health.ucsd.edu](rmckay@health.ucsd.edu)  \n8 Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; [ryanc8@mskcc.org](ryanc8@mskcc.org)  \n9 Desai Sethi Urology Institute and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA; [nimasharifi@miami.edu](nimasharifi@miami.edu)  \n* Correspondence: [anton401@umn.edu](anton401@umn.edu) (E.S.A.); [jhwang@umn.edu](jhwang@umn.edu) (J.H.)† These authors contributed equally to this work.  \nAbstract: HSD3B1 encodes an enzyme that catalyzes the conversion of adrenal precursors into potent sex steroids. A common germline variant (c.1100C) enhances this effect and is linked to breast cancer (BC) progression. As the HSD3B1 genotypes contribute to differences in local and adrenal steroid production, their transcriptional and phenotypic effects on cancers influenced by hormonal signaling such as BC and endometrial cancer (EC)—particularly in relation to menopausal status—remain unclear. We analyzed BC and EC sequenced from patients that received diagnostic tests in oncology clinics, and we determined the germline HSD3B1 c.1100 genotype (A","cbCaibSxDb9zhdfj","https://ap.wps.com/l/cbCaibSxDb9zhdfj","pdf",2483126,21,"English","# Abstract\n# Introduction","[{\"question\":\"What does the HSD3B1 c.1100C germline variant affect in this study?\",\"answer\":\"It evaluates how the HSD3B1 c.1100 genotype (AA, AC, CC) is associated with differences in tumor biology and clinical-related outcomes in breast and endometrial cancers.\"},{\"question\":\"How were HSD3B1 genotypes determined and how was menopausal status inferred?\",\"answer\":\"Genotypes were inferred from tumor DNA sequencing using variant allele frequency, and menopausal status was assumed using age at molecular profiling.\"},{\"question\":\"What main differences were observed between genotypes in breast and endometrial cancers?\",\"answer\":\"In ER+ premenopausal breast cancer, CC tumors showed enrichment of hormone-related pathways; in premenopausal triple-negative breast cancer, AA tumors showed elevated immune/epithelial gene expression and higher MED12 alterations, while in endometrioid endometrial cancer CC tumors suppressed immune and proliferative pathways.\"}]","HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers | PDF",1790171522,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b651ad9ad6bc29c3b26a5cb2a13e9fc2.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/865a6c4368d2cc7d8ba55bfd944df8b5.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1eac8d3c48831d727aa8327e8444b86.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a30ae580493c301941396e1af9336f8.webp",980,1385]